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Leishmania infection causes diverse clinical manifestations in humans. The disease 
outcome is complicated by the combination of many host and parasite factors. Inbred 
mouse strains vary in resistance to Leishmania major but are highly susceptible to 
Leishmania amazonensis infection. However, rats are highly resistant to L. amazonensis 
infection due to unknown mechanisms. We use the inducible nitric oxide synthase (Nos2) 
gene knockout rat model (Nos2−/− rat) to investigate the role of NOS2 against leishmania 
infection in rats. Our results demonstrated that diversion toward the NOS2 pathway is 
the key factor explaining the resistance of rats against L. amazonensis infection. Rats 
deficient in NOS2 are susceptible to L. amazonensis infection even though their immune 
response to infection is still strong. Moreover, adoptive transfer of NOS2 competent 
macrophages into Nos2−/− rats significantly reduced disease development and parasite 
load. Thus, we  conclude that the distinct L-arginine metabolism, observed in rat 
macrophages, is the basis of the strong innate resistance to Leishmania. These data 
highlight that macrophages from different hosts possess distinctive properties and produce 
different outcomes in innate immunity to Leishmania infections.
Keywords: nitric oxide, Leishmania (L.) amazonensis, rat peritoneal macrophages, iNOS knock out, adoptive 
transfer
INTRODUCTION
Leishmaniasis, caused by Leishmania spp., is responsible for a wide spectrum of human diseases 
ranging from cutaneous leishmaniasis (CL), through mucocutaneous leishmaniasis (MCL) to 
the fatal form of visceral leishmaniasis (VL; Murray et  al., 2005). It is endemic in 98 countries 
rendering approximately 350 million people at risk of infection worldwide (World Health 
Organization, 2010). Leishmania species are obligate intracellular protozoan parasites in the 
mammalian host and reside as aflagellated amastigote forms that primarily infect phagocytes, 
but exist as flagellated promastigotes in the gut of infected sandflies (Kaye and Scott, 2011).
The outcome of leishmaniasis is governed by both host and parasite factors (Alexander 
et  al., 1999; Kaye and Scott, 2011). Experimental models of leishmaniasis have provided a 
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large amount of useful data which have helped to elucidate 
the host immune defense mechanism against infection. Mouse 
models have been extensively exploited to investigate the host 
factors that might be responsible for resistance or susceptibility 
to infection. For instance, most inbred mouse strains are highly 
susceptible to L. amazonensis infection (Barral et  al., 1983; 
Calabrese and da Costa, 1992; Soong et  al., 1997). However, 
the best recognized model is the Leishmania major model of 
cutaneous leishmaniasis where inbred strains of mice vary in 
their ability to control L. major infection. For example, in 
BALB/c mice, susceptibility is due to the development of a 
dominant type 2 helper T-cell (Th2) suppressive immune 
response, while in resistant C57BL/6 mice, they are able to 
mount an effective Th1 response. This means that host resistance/
susceptibility is influenced by expansion of distinct helper T-cell 
subsets that are followed by the production of divergent cytokine 
profiles and macrophage function (Muller et  al., 1989; Sacks 
and Noben-Trauth, 2002). Macrophages comprise the majority 
of Leishmania-infected cells and are the main effector cells 
that decide the fate of intracellular amastigotes. In the context 
of a Th1 response, macrophage inducible nitric oxide synthase 
(NOS2) is activated to produce nitric oxide (NO), resulting 
in the destruction of intracellular amastigotes. However, in 
the Th2 response, alternatively activated macrophages upregulate 
arginase expression that suppresses NOS2 activity and leads 
to uncontrolled parasite proliferation (Liew et al., 1991; Stenger 
et  al., 1994; Wei et  al., 1995; MacMicking et  al., 1997). The 
hamster model is another frequently used model for leishmaniasis 
because it has clinical manifestations that closely mimic that 
of humans. Hamsters are highly susceptible to Leishmania 
infection due to the lack of a binding sequence for nuclear 
factor interleukin-6 (NF-IL-6) within the Nos2 promoter, 
rendering it refractory to activation by IFN-γ/LPS, and resulting 
in impaired NOS2-mediated intracellular killing (Melby et  al., 
2001; Perez et  al., 2006; Saldarriaga et  al., 2012).
In a remarkable contrast to mice and hamsters, rats (Rattus 
rattus and others) in the laboratory are highly resistant to 
Leishmania infection (Giannini, 1985). Rats are frequently used 
as animal models in many biological studies (e.g., physiology, 
transplantation, medicine, and cancer) as they differ in many 
aspects when compared with mice. Very limited experimental 
work has been reported on the use of rats for investigating 
Leishmania infection. In the choice of an animal model to 
investigate host immune defense mechanisms against pathogens, 
the rat model is usually overlooked in favor of the mouse 
model. This probably results from the following facts: 1. Mice 
are generally susceptible to many infectious agents and easy 
to establish infection. 2. Transgenics and knockouts in mice 
are generally easy to produce, and there are multiple genetically 
engineered mice that are already available worldwide. 3. 
Immunological reagents and tools are readily available for mice 
while somewhat limited in rats. However, rats are generally 
more resistant than mice to many pathogen infections – thus 
offering an opportunity to explore mechanisms of resistance. 
This host difference is commonly, and traditionally, explained 
by host specificity but generally these explanations lack a clearly 
identified factor or process. It suggests that there should 
be  striking differences in the immune response (innate or 
adaptive) between rats and mice during pathogen infection. 
Therefore, elucidation of the mechanisms of rat resistance to 
pathogen infection would provide an important impact on 
our understanding of the differences in the innate immunity 
between rats and mice.
In this study, a rat model of Leishmania amazonensis infection 
has been used to investigate the rat determinants that drive 
resistance to Leishmania infection. Leishmania is an obligate 
parasite that infects macrophage lineages, thus providing an 
excellent model to focus on macrophage function during 
infection. L. amazonensis was chosen because it is one of the 
most virulent species in the genus Leishmania and possesses 
powerful mechanisms to subvert the host protective immune 
response (Soong, 2012). In this work, we  demonstrate that rat 
macrophages possess a significantly different L-arginine 
metabolism from mouse macrophages. This is characterized 
by the predominant usage of L-arginine by the NOS2 pathway, 
which confers strong resistance to Leishmania infection.
MATERIALS AND METHODS
Animals
Female Sprague Dawley (SD) rats, BALB/c mice, and C57BL/6 
mice were purchased from Zhongshan School of Medicine, 
Sun Yat-Sen University (SYSU), Guangzhou. Female Nos2−/− SD 
rats were generated by TALENs and bred in the animal facility 
of SYSU (Shen et  al., 2017). All the animals were maintained 
in specific pathogen-free conditions. Protocols for the use of 
animals were approved by the Institutional Review Board for 
Animal Care at Sun Yat-Sen University (NO:31472058).
Antibodies and Reagents
Monoclonal antibodies used for phenotypic and intracellular 
cytokine analyses: isothiocyanate (FITC)-anti-CD3, PE-Cy7-
labeled anti-CD4, and peridinin-chlorophyll protein (PerCP)-
labeled anti-CD8 were purchased from BD Biosciences (San 
Jose, CA). Rat ELISA kits for cytokine IFN-γ and IL-4 were 
purchased from BD Biosciences.
Parasites and Culture
Leishmania amazonensis LV78 (RAT/BA/74/LV78) causes 
only cutaneous infection, a clone expressing enhanced green 
fluorescent protein (eGFP) was kindly provided by Dr. K. 
P. Chang. This parasite showed no difference in infection 
virulence to macrophages or mice compared to the wild-
type strain (Chan et  al., 2003). The amastigotes of the LV78 
strain were freshly isolated from footpad lesions of previously 
infected BALB/c mice and transformed into promastigotes 
in Schneider’s insect medium (SDM, pH 6.9) supplemented 
with 10% FBS (Hyclone) at 26°C. The parasites at stationary 
phase (day 5 culture) were used for in vitro or in vivo 
infection. Only 2 to 9 passages were used in subculture of 
the parasites in order to make sure that virulence of the 
parasites was maintained for infection.
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Isolation of Peritoneal Macrophages and 
Infection With Leishmania
Naïve peritoneal macrophages were isolated by peritoneal lavage 
with ice-cold D-hanks buffer as described preciously (Li et  al., 
2012). Briefly, WT and Nos2−/− rats (females, 9 weeks old) were 
sacrificed by CO2 asphyxia. A total of 20 ml ice-cold D-hanks 
buffer were injected into the peritoneal cavity and then withdrawn. 
Cells were collected by centrifugation and resuspended in RPMI-
1640 (without phenol red) supplemented with 10% FBS and 100 U/
ml penicillin and streptomycin. Then, 5 × 105 macrophages were 
seeded into each well of a 24-well plate with 500 μl medium. 
Four hours later, unattached cells were removed by washing twice 
with pre-warmed D-hanks buffer to obtain macrophages. 
Macrophages were allowed to culture overnight before infection. 
LV78 promastigotes from stationary culture were washed 3 times 
in D-hanks buffer, resuspended in complete RPMI-1640 medium, 
and adjusted to a final concentration of 2.5 × 107. Aliquots of 
100 μl were put into each well of a 24-well plate with a ratio of 
parasites to macrophages of 5:1. They were then incubated at 
35°C with 5% CO2 for 6 h, and free promastigotes were removed 
by washing 3 times with pre-warmed D-hanks. Cells were treated 
with or without various combinations of IFN-γ (50 ng/ml) and 
aminoguanidine (AG, 5 mM). Culture supernatants were collected 
at indicated time points to determine the production of NO. At 
0, 24, 48, and 72 h postinfection, and parasite proliferation was 
determined by counting at least 300 macrophages to enumerate 
the percentage of cells infected and amastigotes per 100 macrophages.
Determination of Nitric Oxide Production
Culture supernatants were collected from treated cells. Proteins 
were removed by adding ZnSO4 to a final concentration of 
30 mg/ml, and the liquid was thoroughly vortexed and centrifuged 
at 8,000 g for 10 min. Then, 100 μl of total supernatant was 
mixed with 100 μl Griess reagent and incubated in the dark 
for 10 min; the absorbance was read at 540 nm, and nitrite 
concentrations were calculated against a standard curve.
Determination of Arginase Activity
Arginase activity of macrophages was measured by a colorimetric 
method as described (Corraliza et al., 1995). Ten mm MnCl2 
and 0.5 M L-arginine were successively added to macrophage 
lysates for 1 h at 37°C. The reaction was stopped by addition 
of an acid solution (H2SO4: H3PO4: H2O = 1:3:7), and the urea 
generated by arginase was analyzed by addition of 
a-isonitrosopropiophenone at 100°C for 45 min. The colored 
product was quantified by absorption at 550 nm in an ELISA 
reader. Arginase activity was determined as the amount of urea 
produced from total protein of peritoneal macrophages.
Infection of Animals and Determination of 
Lesion Development
Groups of WT, heterozygous (Het), and Nos2−/− SD rat (n = 12, 
in each group, 4 weeks old) were subcutaneously infected in 
the left ear with 107 stationary phase L. amazonensis LV78 
promastigotes, using a 30 G needle, in a volume of 10 μl PBS, 
while the control rat ear received 10 μl PBS without parasites. 
Uninfected rats of the same age were used as controls. The 
lesion thickness and diameter were measured every 4 or 8 days 
with a dial caliper. Lesion thickness was calculated by subtracting 
the thickness of the control ear from the infected ear, while 
lesion diameter was measured as the longest axis of the ear lesion.
Estimation of Parasite Load by Limiting 
Dilution Assay
At 32 and 64 days postinfection, 3 rats per group were sacrificed 
and the parasite load in the infected ears was estimated by 
using a limiting dilution assay as previously described with 
modification (Belkaid et  al., 2000). Briefly, the infected ears 
were cutoff, and their surfaces were disinfected in 70% ethanol, 
and the dorsal and ventral part of the ear were separated with 
forceps. The two ear leaflets were placed dermal side down 
on SDM containing 1 mg/ml collagenase 1 (Sigma) and digested 
for 2 h in 37°C. Then, the dermal sheets were cut into small 
pieces and homogenized in a glass tissue homogenizer with 
2 ml SDM followed by the liquid being passed through a 70 μm 
cell strainer (Falcon, BD) to obtain a single cell suspension. 
Serial 10-fold dilutions were made with SDM supplemented 
with 10% FBS and 5% defibrinated rabbit whole blood lysate, 
and aliquots of 100 μl were distributed in 96-well plates with 
12 wells per dilution. The plates were kept at 26°C for up to 
two weeks, and the number of parasites was determined by 
the highest dilution for which the parasites could be  grown.
Histopathology
Infected ears were collected and fixed in 4% paraformaldehyde 
for 24 h. They were dehydrated with gradient solutions of 
ethanol and embedded in paraffin. The tissue specimens were 
sliced to a thickness of 5 μm and stained with hematoxylin 
and eosin. All histological sections were observed by light 
microscopy (Leica DM 2500B, Germany).
Preparation of Soluble Leishmania Antigen
L. amazonensis LV78 promastigotes were grown to stationary 
phase in SDM and were collected and washed three times in 
PBS and then resuspended in PBS at 109/ml. The cells were 
subjected to 10 cycles of rapid freezing (−70°C) and thawing at 
(37°C) for lysis and centrifuged at 12,000 rpm at 4°C for 10 min, 
and the supernatants were then collected and passed through a 
0.20-μl filter assembly. The protein concentration was determined 
by a BCA kit. SLA was stored at −70°C until use.
Analysis of Immune Cell Responses
At 32 days postinfection, immune cells from Leishmania-infected 
WT and Nos2−/− SD rats were isolated for analysis. PBMCs were 
isolated by Ficoll-Hypaque (Tianjin Hao Yang Biological 
Manufacture, Tianjin, China) density gradient centrifugation. Briefly, 
cells were suspended in Hank’s buffer and gently added on top 
of the Ficoll solution, and the ratio of cell suspension to Ficoll 
was 4:3 and centrifuged at a speed of 2,200 rpm for 20 min. The 
cells in the second upper layer were harvested for mononuclear 
leukocytes and washed twice with D-Hanks. Spleen and lymph 
nodes cells were separated by traditional methods. Briefly, the 
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spleens and mesenteric lymph nodes from rats were mashed to 
release the cells and they were then passed through a 70 μm cell 
strainer to obtain single cells. Red blood cells were removed using 
ammonium chloride as a lysing reagent, and immune cells were 
then washed with D-Hanks buffer and resuspended in RPMI-
1640 supplemented with 10% FBS. Cells were counted and seeded 
into each well of a 96-well plate with 2 ×  105 cell/ml. Cells were 
stimulated with SLA (25 μg/ml) for 48 h. IFN-γ and IL-4 production 
in the supernatants were determined by ELISA.
Cytokine ELISA
Supernatant from SLA-stimulated cells were assayed for IFN-γ 
and IL-4 with rat ELISA kits (BD Biosciences). Absorbances 
were read at 405 nm using a microtiter plate reader. 
Concentrations were determined using standard curves for each 
cytokine. The detection limits of IFN-γ and IL-4 assay kits 
were 31.25 and 1.6 pg./ml, respectively.
Serum Cytokine Analysis
Rat serum was collected at 16, 48, and 64 days postinfection, 
and cytokines were analyzed by Multiplex Luminex using 
ProcartaPlex Rat Th Complete Panel (ProcartaPlex, eBioscience), 
according to the manufacturer’s instructions.
Isolation of Rat Bone Marrow-Derived 
Macrophages and Transfer to Infected 
Nos2−/− Rats
Bone marrow-derived macrophages (BMDMs) were generated 
as previously described with modification (Boltz-Nitulescu et al., 
1987). Briefly, bone marrow cells were obtained by flushing 
femurs of adult SD rats with D-Hanks buffer, cells were then 
dispersed by passing through a needle, and erythrocytes were 
removed by lysis with 0.015 M Tris-NH4Cl (pH 7.4). The cells 
were then washed and resuspended in DMEM supplemented 
with 10% FBS and 30% L929 cell supernatant. The cells were 
cultured in a 75 cm2 TC flask for 3 days with a change in 
fresh medium for another 4 days. Then, the BMDMs were 
harvested by digestion with 0.5% trypsin containing 0.03% 
EDTA. The harvested BMDMs were washed 3 times in PBS 
and adjusted to 107 cells/ml in PBS. The cells were i.v. injected 
into the recipient Nos2−/− rat at 0, 8, 16, and 24 DPI.
Statistical Analyses
Statistical differences between groups were analyzed with Student’s 
t test using a built-in module of GraphPad Prism v5.0 (GraphPad 
software), using p < 0.05 as the level of significance.
RESULTS
NOS2 Activity Is Essential for Rat 
Peritoneal Macrophage Resistance 
Against L. amazonensis Infection
To investigate the mechanism of rat resistance against Leishmania 
infection, macrophages were targeted since they play a crucial 
role in the host innate immune response and are the major 
cell type inhabited by Leishmania during infection (Rittig and 
Bogdan, 2000). Naïve peritoneal macrophages were isolated 
from mice and Sprague Dawley (SD) rats and infected with 
L. amazonensis in vitro. In accordance with previous studies 
(Giannini, 1985; Soong et  al., 1997), macrophages from both 
BALB/c and C57BL/6 mice are susceptible to L. amazonensis 
infection as indicated by unrestrained intracellular parasite 
replication during infection and by NO being absent in the 
culture supernatant (Figures  1A,D). In contrast, macrophages 
from SD rats showed restrained L. amazonensis growth, with 
intracellular amastigotes remaining low and only showing a 
slight increase at 72 h postinfection (HPI). A considerable 
amount of NO was detected in the culture supernatant 
(Figures  1A,D). Nitric oxide (NO), produced by NOS2, has 
been shown to be  the key antimicrobial agent found in 
macrophages, and its induction is critical in the control of 
many intracellular pathogens (Li et al., 2012). Therefore, we tested 
whether NO is important for conferring resistance to Leishmania 
infection in rat macrophages by inhibition of NOS2 activity 
with a specific inhibitor aminoguanidine (AG; Griffiths et  al., 
1993). When NOS2 was inhibited by AG, NO was not detected 
and parasite replication increased significantly, suggesting that 
NOS2 activity is indispensable in resistance (Figures  1A,D). 
To further dissect the role of NOS2, we  generated an Nos2 
gene knockout SD (Nos2−/−) rat using transcription activator-
like effector nuclease technology (TALENs; Tesson et al., 2011). 
TALENs resulted in a two-nucleotide deletion in the open 
reading frame of the Nos2 gene (Supplementary Figure  1A). 
Disruption of the Nos2 gene was demonstrated by the absence 
of NOS2 proteins in naïve or activated peritoneal macrophages 
and the absence of NO production in the culture supernatant 
of the activated macrophages (Supplementary Figures  1B,C), 
while arginase activity showed no significant difference between 
the wild-type and Nos2−/− macrophages (Figure 1F). Macrophages 
from Nos2−/− rats showed a significant increase in parasite 
burden compared to the macrophages from the wild-type rats 
at 72 h postinfection (HPI; Figure 1C). More importantly, they 
failed to eliminate amastigotes even in the presence of IFN-γ, 
unlike the macrophages from the wild-type rats (Figures 1B,C). 
These observations clearly demonstrate that the parasite growth 
in NOS2 inhibited wild-type or Nos2−/− macrophages was caused 
by the lack of NO production (Figure  1). The slight reduction 
in the parasite burden in the Nos2−/− rat macrophages after 
IFN-γ activation indicates that NO-independent killing of 
L. amazonensis might exist. However, it must play a minor 
role, since most of the parasites remain intact, indicating that 
NO is the predominant leishmanicidal effector in rat 
peritoneal macrophages.
Rats Lacking NOS2 Lose Innate 
Resistance to L. amazonensis Infection 
and Develop Progressive Lesions
The above results demonstrate the critical role of NOS2 for rat 
macrophage resistance against L. amazonensis infection in vitro. 
We  employed a rat ear cutaneous infection model to further 
investigate the role of NOS2 in vivo. Wild-type (WT), heterozygous 
(Het), and Nos2−/− SD rats (Nos2−/−) were subcutaneously infected 
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with 107 stationary phase promastigotes of L. amazonensis. 
Interestingly, the results showed that all the Nos2−/− SD rats were 
highly susceptible to L. amazonensis infection compared to their 
wild-type SD and Het counterparts. In all Nos2−/− rats, lesions 
began to appear at 8 days postinfection (DPI). Afterward, the 
lesions became progressively worse as shown by an increase in 
thickness and diameter. The increase in lesion pathology (thickness 
and diameter) occurred rapidly from 8 to 40 DPI, then levelled 
off, and did not show any sign of recovery (Figures  2A,B). In 
contrast to mouse strains and Nos2−/− rats, the resistance to 
infection in wild-type SD rats was demonstrated by observing 
only a temporary mild swelling or even absence of swelling, in 
some animals, during the course of the experiment. At the end 
of the experiment (56–64 DPI), no lesions were found in any 
WT rats. Het rats developed moderate lesions at the early stages 
of infection but were also able to heal afterward. Hematoxylin-
Eosin (HE)-stained sections of ear lesions at 32 DPI revealed 
that, in the Nos2−/− rat, the cutaneous tissue in the thickened 
ear was dominated by an increased infiltration of inflammatory 
cells. However, unlike observations in mice (Vasconcellos and 
Sotto, 1997), granulomas were not observed at the site of the 
infection in rats even though there was extensive cell infiltration. 
Furthermore, the general structure of the ear was not affected. 
Some recruited cells in the Nos2−/− rats harbored numerous 
amastigotes, indicating their inability to kill parasites 
(Figures  2D,E,G). In sharp contrast, the structure of the dermal 
tissue from the ear of wild-type rats remained either normal at 
32 DPI or with a few cells infiltrating if mild swelling was 
present. However, we  were unable to observe any amastigotes 
in the sections of WT ears, indicating that most of the injected 
parasites were eliminated (Figures  2D,F). The parasite burden 
of infected ears was estimated at 32 and 64 DPI, by a limiting 
dilution assay. The parasite load in lesions was much higher in 
Nos2−/− rats than in the wild-type and Het rats. At 32 DPI, 
parasite load in the Nos2−/− rats was almost 330-fold greater 
than that observed in WT rats. Furthermore, the parasite burden 
declined rapidly to an undetectable point in WT rats at 64 DPI 
while it persisted in Nos2−/− rats. The parasite load in the Het 
rats was higher than that observed for WT rats at 32 DPI 
(p = 0.027), but they were almost eliminated at 64 DPI (Figure 2C). 
The above results demonstrate that NOS2 was also indispensable 
for rat innate resistance to L. amazonensis in vivo.
Rats Lacking NOS2 Present Normal 
Leishmania-Induced Specific Immune 
Responses After Infection
The above results have shown that NOS2 plays a pivotal role in 
rat resistance against Leishmania infection, both in vitro and in 
vivo. Since NO has been shown to participate in both antimicrobial 
A B C
D E F
FIGURE 1 | NOS2 activity is indispensable for rat macrophage resistance to L. amazonensis infection in vitro. A,C, Peritoneal macrophages from BALB/C, 
C57BL/6 mice, wild-type SD rats (SD, WT), or Nos2−/− SD rats (Nos2−/−) were incubated with L. amazonensis promastigotes, with 5 mm aminoguanidine (AG) or 
50 ng/ml recombinant rat IFN-γ, if indicated. The number of amastigotes per 100 macrophages (A,C) and percentage of macrophages infected (B) were shown. 
(D,F), Corresponding NO production (D,E) and urea production (F) in culture supernatants at 24 h postinfection were determined. The data (mean ± SD amastigotes 
per macrophage) were derived from a single representative of three independent experiments. **indicates a significant difference (0.001 ﹤ P ﹤ 0.01), ***(P ﹤ 0.001).
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activity and immune regulation in mice (Taylor-Robinson et  al., 
1994; Diefenbach et  al., 1999), it is important to know whether 
rats deficient in NOS2 are capable of mounting an effective 
immune response toward Leishmania. Naïve Nos2−/− rats did not 
show any observed abnormalities in the differentiation of CD4+ 
or CD8+ T-cell subsets (Supplementary Figure 2), as has previously 
been reported for NOS2-deficient mice (Wei et  al., 1995). Both 
wild-type and Nos2−/− groups of rats were each subcutaneously 
infected with 107 l. amazonensis via the dermal tissue in the ear. 
Then, peripheral blood mononuclear cells (PBMCs), splenocytes, 
and mesenteric lymph node (LN) cells were isolated 32 DPI and 
stimulated with soluble Leishmania antigens (SLA). Culture 
supernatants were assayed for IFN-γ and IL-4 production by 
ELISA. Splenocytes and LN cells from both WT and Nos2−/−-
infected rats produced comparable amounts of IFN-γ, while a 
significantly higher concentration of IFN-γ in PBMCs was detected 
in the Nos2−/− group than that in the WT group (p = 0.0014; 
Figure 3), indicating that Nos2−/− rats are able to mount a strong 
Leishmania-specific immune response. The higher level of production 
of IFN-γ in Nos2−/− rats is presumably due to the persistence of 
greater numbers of parasites in the ear dermis, thus eliciting 
more parasite antigen to be  recognized by the immune cells. 
IL-4 was also detected in both Nos2−/− and WT rat cells.
Serum cytokines profiles were measured to better understand 
the immune status in these rats. Inflammatory cytokines were 
significantly higher in Nos2−/− rats but low to undetectable in 
WT rats (Figure  4). IFN-γ, TNF-α, IL-12, IL-1β, and IL-6 
are important pro-inflammatory mediators during tissue 
inflammation. An increase in these cytokines was observed in 




FIGURE 2 | Rats deficient in NOS2 are susceptible and parasites were not controlled. Wild-type (WT), heterozygous (Het; N = 12), and Nos2−/− (Nos2−/−; N = 12) SD 
rats were subcutaneously infected with 107 l. amazonensis LV78 in the left ear. Lesion thickness (A), and diameter (B) were shown as mean ± SD. 0–32 days 
postinfection (DPI), N = 12; 40–64 DPI, N = 6. The parasite load (C) in the lesion was determined by limiting dilution assay (N = 3, mean ± SD). The outlook of 
representative infected ears (D). (E–G), HE-stained sections of infected ear at 32 DPI. Inset in G shows multiple amastigotes. Scale bar, 20 μm. ND: not detectable 
(﹤20). *** indicates a significant difference (P ﹤ 0.001).
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tissue inflammation persisted and was intense. Furthermore, 
this further supports the evidence that the Nos2−/− rats were 
capable of mounting a specific immune response to Leishmania.
Adoptive Transfer of Wild-Type Bone 
Marrow-Derived Macrophages to Nos2−/− 
Rats Delayed Early Lesion Formation and 
Reduced Parasite Burden
The above results provided strong evidence for the important 
role of NOS2 against Leishmania infection in rats. Since the 
immune regulatory network in Nos2−/− rats is unimpaired, 
we  therefore sought to investigate the role of macrophages in 
the rat model by adoptive transfer of BMDM from WT rats to 
the Nos2−/− rats. In the Nos2−/− rats that received WT BMDMs, 
the onset of the lesion development was delayed and shifted 
from 8 DPI to 16 DPI (Figure  5). Meanwhile, both the lesion 
thickness and diameter were significantly lower than in the untreated 
group prior to 20 DPI. However, lesions in the treated group 
developed progressively at a later time point (16–32 DPI). The 
lesion thickness increased to the same level as the untreated group 
but the diameter was still lower at 32 DPI. Nevertheless, the 
Nos2−/− rats receiving wild-type BMDMs harbored significantly 
less parasites in lesions compared with the untreated group. These 
results provided further evidence that macrophages with NOS2 
function play an important role in the control of parasites in vivo.
DISCUSSION
There is a basic question as to why rats are much more resistant 
to Leishmania spp. infection than mice? Host specificity is a 
commonly used answer. But what is the mechanism underpinning 
such specificity? So far as we  know, before we  started our 
study, this remained as a black box. To address the question 
of why rats are much more resistant to pathogen infection 
than mice, our group previously reported that the high basal 
NOS2 but low basal arginase activity in rat peritoneal 
macrophages were linked to their resistance to Toxoplasma 
infection (Li et al., 2012). Furthermore, results from a comparison 
of rat alveolar macrophages (sensitive to Toxoplasma infection) 
with rat peritoneal macrophages (resistant to Toxoplasma 
infection) showed that this difference was correlated with low 
and high NOS2 expression, respectively (Zhao et  al., 2013). 
Additionally, differing levels of resistance and susceptibility to 
T. gondii in different inbred rat strains were correlated with 
the expression of NOS2 (Gao et  al., 2015). More recently, 
we  found that nitric oxide plays a key role in blocking the 
development of the human parasite Schistosoma japonicum 
in the rat (Shen et  al., 2017). However, arguments still exist 
about the distinctive differences between Toxoplasma and 
Leishmania infection. Toxoplasma can infect almost all cells 
with a nucleus, while Leishmania almost only infects phagocytes 
but predominantly macrophages.
To exclude the possibility that other mechanisms, rather 
than L-arginine metabolism, play the key functional role in 
host specificity, our study used an even more simple model 
to address this question. As Leishmania infects only macrophages, 
a Nos2 gene knockout model system can be used to investigate 
the role of NOS2  in the resistance to Leishmania infection in 
rats. The importance of macrophage NOS2  in rat resistance 
to Leishmania has been demonstrated both in vitro and in 
vivo by the following evidence: 1. Enhanced intracellular survival 
and replication of amastigotes in NOS2 inhibited wild-type 
macrophages or Nos2−/− macrophages, 2. inability to eliminate 
FIGURE 3 | IFN-γ and IL-4 production in rat immune cells stimulated with SLA. 2 × 105 PBMCs, LN, and spleen cells were isolated and treated with 50 μg/ml 
soluble Leishmania antigens (SLA); IFN-γ and IL-4 production were determined from culture supernatants at 48 h post-treatment (N = 6, mean ± SD). ** indicates a 
significant difference (0.001 ﹤ P ﹤ 0.01);*** (P ﹤ 0.001).
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amastigotes after activation with IFN-γ in Nos2-deficient 
macrophages, 3. subclinical infection and parasite elimination 
in wild-type rats compared with progressive lesion development 
and persistent parasitemia in Nos2−/− rats, even though the 
immune response was unimpaired, and 4. transfer of macrophages 
collected from wild-type rats into Nos2−/− rats delayed lesion 
formation and reduced parasite load.
As our data mentioned above clearly show, after infection 
with an invading pathogen, L-arginine metabolism is key to 
shaping macrophage function and determines the progression 
of the disease. Macrophages are major players in the first line 
of innate defense against many pathogen infections. It is, 
therefore, fundamental to understand the differences in arginase 
metabolism in macrophages from various hosts and even 
between different human populations. Data from Mills and 
colleagues revealed that macrophages from different mouse 
strains varied in arginine metabolism in response to 
immunological stimuli, such as lipopolysaccharide (LPS) or 
IFN-γ; thus, they classified macrophages that predominately 
express NOS2 or arginase pathways as M1 or M2 macrophages, 
respectively (Mills et al., 2000). However, more striking differences 
exist between mouse and rat macrophages. When rats are used 
as a reference, all mouse macrophages, in different inbred lines, 
were highly polarized toward the M2 state and were characterized 
by prominent arginase activity and undetectable NOS2 activity 
(Li et al., 2012). In contrast, naïve macrophages from rat strains 
were uniformly polarized toward the NOS2 pathway, where 
arginase activity was low, and thus, they are polarized toward 
M1 state. More importantly, this polarization is independent 
of cytokine or microbial product stimulation (Li et  al., 2012). 
Interestingly, other than in the naïve state, rat macrophages 
are also more sensitive to exogenous stimuli than mice 
macrophages, as they are readily activated at a lower LPS 
concentrations or produce higher amounts of NO when treated 
with the same concentration of LPS (Kmonickova et al., 2007). 
Differential tendencies in arginine utilization were also observed 
in macrophages during infection. The inducibility of NOS2 
activity by LPS was found to be much higher in rat macrophages 
than mouse macrophages infected with L. amazonensis. Infected 
rat macrophages produced substantial amounts of NO at low 
LPS concentrations, while mouse macrophages required a much 
higher LPS concentration but only generated limited amounts 
of NO (Supplementary Figure S3). These findings have pointed 
to distinctive differences between macrophage potency in 
generating NO. This may explain why rats, but not mice, are 
able to control subclinical infections of L. amazonensis and 
FIGURE 4 | Serum cytokine profiles of rats infected with Leishmania amazonensis. The serum of Nos2−/− and wild-type rats were collected at 16, 48, and 64 days 
postinfection (DPI). Cytokine levels were determined by multiplex Luminex (N = 3, mean ± SD). ND: not detectable. *indicates a significant difference (0.01 ﹤ P ﹤ 0.05);*** 
(P ﹤ 0.001).
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achieve sterile cure. Therefore, this potentially provides a strong 
mechanistic link to the explanation behind the concept of 
host specificity. Besides the pivotal role of NOS2, the role of 
arginase in rat resistance against Leishmania infection remains 
to be  defined. Interestingly, arginase activity is naturally low 
in rats but high in mice macrophages (Li et  al., 2012). High 
arginase and subsequent polyamine biosynthesis favor parasite 
survival and replication, and this is a biomarker for active 
disease status in VL (Iniesta et  al., 2002; Kropf et  al., 2005; 
Abebe et  al., 2013). Furthermore, evidence has demonstrated 
that inhibition of arginase activity reduces Leishmania growth 
and consequent disease development in infected murine hosts 
(Iniesta et  al., 2001, 2005). Taken together, rat macrophages 
have a propensity to activate the NOS2 pathway during 
L. amazonensis infection with high NO output accompanied 
by limited arginase activity. This then creates a highly detrimental 
microenvironment for Leishmania survival resulting in innate 
resistance. The disruption of the Nos2 gene in the knockout 
rat, and subsequent susceptibility, strongly supports this 
conclusion. Therefore, we  conclude that the host specificity to 
parasites, at least for Leishmania in rat and mouse models, is 
mainly due to differences in L-arginine metabolism and 
polarization toward NOS2 activity.
In our rat model, the deletion of two nucleotides in the 
Nos2 gene of rats reversed its resistance to Leishmania infection. 
In view of the long-term co-evolution of host and parasite, 
the mutation of a single gene is likely to be  common and 
could give rise to different populations that show diversity in 
gene function. The maintenance of a crucial gene that is 
responsible for parasite resistance, such as NOS2, is an important 
selective pressure for the evolution of the host. Any changes 
in the regulatory pathways that enhance the function of these 
genes would promote host survival and expansion, especially 
when the infectious agent is both fatal and present at high 
prevalence. Rats are, therefore, an extraordinary host that is 
highly resistant to many pathogen infections. In contrast, gene 
mutations that weaken or abrogate these genes would favor 
parasite adaptation to the host, such as occurs in mice and 
hamsters that are susceptible to infection. The evolution of 
the Nos2 gene and its regulatory network in different hosts 
is extremely interesting, and the importance of this gene is, 
at least, demonstrated in the rat and mouse. Genomic analysis 
in the rat has shown that rat-specific genes related to immunity 
have appeared through an expansion of gene families, which 
is not seen in the mouse (Gibbs et  al., 2004). Further analysis 
through comparative genomic analysis would be  valuable in 
identifying other genes that confer innate resistance.
In humans, the involvement of NOS2  in protection against 
leishmaniasis has been demonstrated by the finding that higher 
NOS2 expression correlates with fewer parasites in  localized CL, 
while low NOS2 expression correlates with high parasite burden 
in diffuse CL (Qadoumi et  al., 2002). In another example, the 
Tat protein, produced by HIV-1, appears to interfere with protein 
kinase R (PKR) activity which downregulates NOS2 expression 
in macrophages derived from healthy human donors and leads 
to consequent increase in intracellular growth by L. amazonensis 
A B
C
FIGURE 5 | Adoptive transfer of wild-type macrophages to Nos2−/− rats delayed lesion formation and reduced parasite load. Bone marrow cells were isolated from 
wild-type rats, cultured and differentiated to macrophages (BMDMs) in 30% L929 cell conditioned medium. Nos2−/− rats (N = 5) received 3, 5, 5, 8 × 106 wild-type rat 
BMDMs at 0, 8, 16, and 24 days postinfection, respectively. Lesion thickness (A) and diameter (B) were measured every 4 days. (C) Parasite burden (mean ± SD) on 
32 DPI was determined by Limiting dilution assay. * indicates a significant difference (0.01 ﹤ P ﹤ 0.05); **(0.001 ﹤ P ﹤ 0.01); ***(P ﹤ 0.001).
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(Vivarini Ade et  al., 2015). Additionally L. amazonensis, itself, 
may be  responsible for down regulation of NOS2  in human 
and mouse macrophages via the NF-κβ pathway (Calegari-Silva 
et  al., 2015). Furthermore, NOS2 has been shown to participate 
in a variety of other human diseases (Kroncke et  al., 1998). 
The question as to whether NOS2 plays a dominant role in 
human disease is under debate (Albina, 1995; Jungi et al., 1996). 
There has been some evidence that higher NOS2 activity in 
humans correlates with protective immunity to infections 
(Nicholson et  al., 1996). For example, in endemic areas with 
malaria, higher resistance to the disease is present in people 
with higher NO production in macrophages (Anstey et al., 1996). 
Thus, by comparison with species differences in rodents, genetic 
control of differences in NOS2 activity in human populations 
might also exist. A higher NOS2 activity during infection might 
also confer protection. Asymptomatic infections of Leishmania 
in humans have been reported. In infections caused by L. 
infantum, for example, the majority of individuals infected are 
asymptomatic (Michel et  al., 2011). Little is known about the 
differences in immune status between symptomatic and 
asymptomatic patients with leishmaniasis. Investigations into the 
possible involvement of NOS2 might enhance insight into the 
evolution of the Nos2 gene function and population-related 
immunity. Based on our findings in the rat model, we  suggest 
that the status of L-arginine metabolism in macrophages reflects 
host immune function against pathogen infection. High NOS2 
activity is a marker for protective response in resistant hosts, 
while high arginase activity is associated with a suppressed 
immune response in susceptible hosts.
In summary, the results described here show that a distinctive 
L-arginine metabolism featuring high NOS2 activity in rat 
macrophages is responsible for resistance to Leishmania infection. 
Our data indicate that in addition to the extrinsic factors that 
shape macrophage function, rat macrophages independently 
express an innate resistance phenotype to infection. Such 
inherent properties of the innate immune system are linked 
to host specificity for parasite infections in various hosts as 
demonstrated here between rats and mice. This linkage could 
have important implications for the development of 
immunotherapy by targeting L-arginine metabolism in 
leishmaniasis and, perhaps, many other pathogen infections.
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